2013•Journal watchRequires access
Dutasteride Prevents Clinical Progression of Benign Prostatic Hyperplasia in Minimally Symptomatic Men
Paul S. Mueller, FACP. FACP.
Open publisher page 0 citations
Abstract
The 5α-reductase inhibitor dutasteride is used to treat men with symptomatic benign prostatic hyperplasia (BPH). Investigators assessed whether dutasteride prevents clinical progression of BPH in minimally symptomatic men with enlarged prostate glands.
The study involved 1600 men with prostate gland size >40 cc …